Will COVID become a disease of the young?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study.The Lancet. Infectious diseases · 2022
   Trial
2. Spatial and temporal patterns of SARS-CoV-2 infection in uMgungundlovu, KwaZulu-Natal, South Africa.PloS one · 2026
   Article
3. Characteristics, contacts, and relative risk of SARS-CoV-2 infection among children during school closures.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022
   Review
4. Living with COVID-19: Subjective Well-Being in the Second Phase of the Pandemic.Journal of youth and adolescence · 2022
   Article
5. COVID-19 and children: medical impact and collateral damage.Microbial biotechnology · 2022
   Review
6. SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways.Expert review of vaccines · 2022
   Review
7. A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects.Frontiers in immunology · 2022
   Review
8. Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel-The effects of waning immunity and third vaccination dose.PLOS global public health · 2022
   Article
9. Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19.Journal of cardiovascular development and disease · 2021
   Article

Corrections and comments

• Comment on
  Impact of the COVID-19 pandemic on emergency and elective hip surgeries in Norway.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as